Clinical Trial Update: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]

View source ↗

Summary

Phase 3 trial update for C1 Esterase Inhibitor (C1INH-nf) in acute hereditary angioedema attacks has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1 Esterase Inhibitor (C1INH-nf) (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2010-06-02